Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Imke Thuneke"'
Autor:
Thomas Löning, Heinrich M. Schulte, Christoph M. Bamberger, Imke Thuneke, A. M. Bamberger, Insa Erdmann, Lutz Riethdorf, Karin Milde-Langosch
Publikováno v:
Virchows Archiv. 434:423-428
In the present study we investigated the expression of the cell cycle inhibitor p27 in endometrial neoplasia using immunohistochemistry with a p27-specific antibody. Expression of p27 in endometrial carcinomas was compared with expression in the norm
Publikováno v:
Breast Cancer Research and Treatment. 47:153-161
Leukemia inhibitory factor (LIF) is a pleiotropic inflammatory cytokine. A potential role for LIF in the pathogenesis of human breast cancer was recently indicated by the finding that LIF is produced by MDA-MB 231 breast cancer cells and that it stim
Autor:
Insa Erdmann, Imke Thuneke, Heinrich M. Schulte, Ana-Maria Bamberger, Sylvia L. Asa, Christoph M. Bamberger
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 82:3173-3175
The Fas (Apo-1/CD95) ligand (FasL) belongs to the tumor necrosis factor family and acts through its receptor (FasR/ Apo-1/CD95) to induce apoptosis in target cells. FasL is expressed in several immunologically privileged sites. Induction of apoptosis
Publikováno v:
Breast cancer research and treatment. 63(3)
While progesterone is a known differentiation-inducing factor in the human endometrium, for the breast epithelium both proliferation-inducing and -inhibiting effects have been described. Cyclin D1, which is required for cell cycle progression in G1 a